2 Pharma Giants Shine as Wall Street Brings Strong IPOs for Cortexyme and NextCure24/7 Wall Street • 05/09/19
Dermira, Inc. (DERM) CEO Tom Wiggans on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/08/19
Eli Lilly and Company's (LLY) CEO Dave Ricks on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 04/30/19
Eli Lilly's stock sinks after earnings beat but revenue comes up short, hurt by Trulicity and Alimta missesMarket Watch • 04/30/19
Looking for a Growth Stock? 3 Reasons Why Lilly (LLY) is a Solid ChoiceZacks Investment Research • 04/29/19
Dermira (DERM) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseZacks Investment Research • 04/25/19
Eli Lilly's Lartruvo is being pulled from the market, but patients who are already taking the drug will still have access under new programMarket Watch • 04/25/19
Pharma Stock Roundup: AZN Inks Cancer Deal, ABBV, NVS & Others Get Drug ApprovalsZacks Investment Research • 03/29/19
Eli Lilly sheds light on confidential drug pricing. Discloses charges for diabetes medicine HumalogCNBC • 03/25/19